Skip to content
MedsAcross

Brand family

Igalmi

Dexmedetomidine · BioXcel Therapeutics
United States
Presentations
2
Markets
1

Igalmi is a brand of Dexmedetomidine marketed by BioXcel Therapeutics, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Dexmedetomidine
Brand owner
BioXcel Therapeutics
Registered in
United States
Strengths and forms
120 mcg sublingual film, 180 mcg sublingual film

All presentations

MedicineManufacturerRegisterAvailability
Igalmi 120 mcg sublingual filmSublingualBioXcel TherapeuticsUS FDAAvailable on request
Igalmi 180 mcg sublingual filmSublingualBioXcel TherapeuticsUS FDAAvailable on request

Equivalent brands

Other brands of Dexmedetomidine.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Igalmi

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.